Bradbury P - Search Results

1

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.

Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, Quantin X, Westeel V, Gargiulo P, Delfanti S, Tu D, Lee CW, Leighl N, Sederias J, Brown-Walker P, Luo Y, Lantuejoul S, Tsao MS, Scherpereel A, Bradbury P, Laurie SA, Seymour L. Chu Q, et al. Among authors: bradbury p. Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931632 Clinical Trial.

2

Tumor shrinkage and objective response rates: gold standard for oncology efficacy screening trials, or an outdated end point?

Bradbury P, Seymour L. Bradbury P, et al. Cancer J. 2009 Sep-Oct;15(5):354-60. doi: 10.1097/PPO.0b013e3181b9c506. Cancer J. 2009. PMID: 19826353 Review.

3

Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancer.

Bradbury PA, Tu D, Seymour L, Isogai PK, Zhu L, Ng R, Mittmann N, Tsao MS, Evans WK, Shepherd FA, Leighl NB; NCIC Clinical Trials Group Working Group on Economic Analysis. Bradbury PA, et al. J Natl Cancer Inst. 2010 Mar 3;102(5):298-306. doi: 10.1093/jnci/djp518. Epub 2010 Feb 16. J Natl Cancer Inst. 2010. PMID: 20160168

4

Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.

Addison CL, Ding K, Zhao H, Le Maître A, Goss GD, Seymour L, Tsao MS, Shepherd FA, Bradbury PA. Addison CL, et al. J Clin Oncol. 2010 Dec 20;28(36):5247-56. doi: 10.1200/JCO.2010.31.0805. Epub 2010 Nov 15. J Clin Oncol. 2010. PMID: 21079146

5

Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancer.

Jang RW, Isogai PK, Mittmann N, Bradbury PA, Shepherd FA, Feld R, Leighl NB. Jang RW, et al. J Thorac Oncol. 2010 Dec;5(12):1953-7. doi: 10.1097/jto.0b013e3181f77a6a. J Thorac Oncol. 2010. PMID: 21155140 Free article.

6

An economic analysis of the INTEREST trial, a randomized trial of docetaxel versus gefitinib as second-/third-line therapy in advanced non-small-cell lung cancer.

Horgan AM, Bradbury PA, Amir E, Ng R, Douillard JY, Kim ES, Shepherd FA, Leighl NB. Horgan AM, et al. Among authors: bradbury pa. Ann Oncol. 2011 Aug;22(8):1805-11. doi: 10.1093/annonc/mdq682. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273345 Free article.

7

Capecitabine or infusional 5-fluorouracil for gastroesophageal cancer: a cost-consequence analysis.

Horgan AM, Knox JJ, Liu G, Sahi C, Bradbury PA, Leighl NB. Horgan AM, et al. Among authors: bradbury pa. Curr Oncol. 2011 Apr;18(2):e64-70. doi: 10.3747/co.v18i2.730. Curr Oncol. 2011. PMID: 21505591 Free PMC article.

8

Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancer.

Navaratnam S, Skliris G, Qing G, Banerji S, Badiani K, Tu D, Bradbury PA, Leighl NB, Shepherd FA, Nowatzki J, Demers A, Murphy L. Navaratnam S, et al. Horm Cancer. 2012 Jun;3(3):93-100. doi: 10.1007/s12672-012-0105-y. Horm Cancer. 2012. PMID: 22302352 Free PMC article.

9

An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.

Hilton JF, Tu D, Seymour L, Shepherd FA, Bradbury PA. Hilton JF, et al. Among authors: bradbury pa. Lung Cancer. 2013 Oct;82(1):136-42. doi: 10.1016/j.lungcan.2013.06.008. Epub 2013 Jul 31. Lung Cancer. 2013. PMID: 23910908

10

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial).

Reaume MN, Leighl NB, Mittmann N, Coyle D, Hirsh V, Seymour L, Tu D, Shepherd FA, Graham B, Gridelli C, Perrone F, Di Maio M, Bradbury PA, Evans WK. Reaume MN, et al. Lung Cancer. 2013 Oct;82(1):115-20. doi: 10.1016/j.lungcan.2013.07.012. Epub 2013 Aug 17. Lung Cancer. 2013. PMID: 23962449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page